DIN 02559323 — LUPIN-LETERMOVIR 240 MG
LUPIN-LETERMOVIR is a tablet of Letermovir marketed by LUPIN PHARMA CANADA LIMITED. The full Letermovir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02559323
- Brand name
- LUPIN-LETERMOVIR
- Active ingredient
- Letermovir
- Strength
- 240 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- LUPIN PHARMA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Antiviral agent (CMV DNA terminase complex inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Letermovir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02559331 | LUPIN-LETERMOVIR | 480 MG | TABLET | LUPIN PHARMA CANADA LIMITED | MARKETED |
| 02469367 | PREVYMIS | 20 MG | SOLUTION | MERCK CANADA INC | MARKETED |
| 02469375 | PREVYMIS | 240 MG | TABLET | MERCK CANADA INC | MARKETED |
| 02469383 | PREVYMIS | 480 MG | TABLET | MERCK CANADA INC | MARKETED |